China Pioneer Pharma Holdings Limited (1345.HK)

HKD 2.34

(-0.43%)

Operating Expenses Summary of China Pioneer Pharma Holdings Limited

China Pioneer Pharma Holdings Limited's latest annual operating expenses in 2023 was 488.03 Million CNY , down -1.72% from previous year.
China Pioneer Pharma Holdings Limited's latest quarterly operating expenses in 2023 FY was 488.03 Million CNY , down -1.72% from previous quarter.
China Pioneer Pharma Holdings Limited reported a annual operating expenses of 496.55 Million CNY in annual operating expenses 2022, down -13.58% from previous year.
China Pioneer Pharma Holdings Limited reported a annual operating expenses of 574.59 Million CNY in annual operating expenses 2021, up 10.72% from previous year.
China Pioneer Pharma Holdings Limited reported a quarterly operating expenses of 488.03 Million CNY for 2023 FY, down -1.72% from previous quarter.
China Pioneer Pharma Holdings Limited reported a quarterly operating expenses of 227.56 Million CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Expenses Chart of China Pioneer Pharma Holdings Limited (2023 - 2010)

Historical Annual Operating Expenses of China Pioneer Pharma Holdings Limited (2023 - 2010)

Year	Operating Expenses	Operating Expenses Growth
2023	488.03 Million CNY	-1.72%
2022	496.55 Million CNY	-13.58%
2021	574.59 Million CNY	10.72%
2020	518.97 Million CNY	-4.48%
2019	543.33 Million CNY	0.32%
2018	541.6 Million CNY	26.43%
2017	428.38 Million CNY	32.23%
2016	323.96 Million CNY	17.04%
2015	276.78 Million CNY	31.64%
2014	210.25 Million CNY	85.31%
2013	113.45 Million CNY	3.73%
2012	109.37 Million CNY	38.29%
2011	79.09 Million CNY	11.26%
2010	71.08 Million CNY	0.0%

Year	Operating Expenses	Operating Expenses Growth
2023 Q4	261.76 Million CNY	0.0%
2023 FY	488.03 Million CNY	-1.72%
2023 Q2	227.56 Million CNY	0.0%
2022 Q4	284.4 Million CNY	0.0%
2022 Q2	212.14 Million CNY	0.0%
2022 FY	496.55 Million CNY	-13.58%
2021 FY	574.59 Million CNY	10.72%
2021 Q2	283.33 Million CNY	0.0%
2021 Q4	291.26 Million CNY	0.0%
2020 FY	518.97 Million CNY	-4.48%
2020 Q2	194.41 Million CNY	0.0%
2020 Q4	324.55 Million CNY	0.0%
2019 Q4	334.8 Million CNY	0.0%
2019 Q2	208.53 Million CNY	0.0%
2019 FY	543.33 Million CNY	0.32%
2018 Q2	205.27 Million CNY	0.0%
2018 FY	541.6 Million CNY	26.43%
2018 Q4	336.33 Million CNY	0.0%
2017 Q4	251.56 Million CNY	0.0%
2017 Q2	176.81 Million CNY	0.0%
2017 FY	428.38 Million CNY	32.23%
2016 Q4	183.7 Million CNY	0.0%
2016 Q2	140.25 Million CNY	0.0%
2016 FY	323.96 Million CNY	17.04%
2015 FY	276.78 Million CNY	31.64%
2015 Q2	84.72 Million CNY	0.0%
2015 Q4	192.06 Million CNY	0.0%
2014 FY	210.25 Million CNY	85.31%
2014 Q2	94.38 Million CNY	0.0%
2014 Q4	115.87 Million CNY	0.0%
2013 Q2	41.26 Million CNY	0.0%
2013 Q4	72.19 Million CNY	0.0%
2013 FY	113.45 Million CNY	3.73%
2012 Q4	24.72 Million CNY	-9.59%
2012 Q2	27.34 Million CNY	0.0%
2012 Q3	27.34 Million CNY	0.0%
2012 Q1	27.34 Million CNY	0.0%
2012 FY	109.37 Million CNY	38.29%
2011 Q1	19.77 Million CNY	0.0%
2011 Q3	19.77 Million CNY	0.0%
2011 Q2	19.77 Million CNY	0.0%
2011 Q4	27.34 Million CNY	38.29%
2011 FY	79.09 Million CNY	11.26%
2010 FY	71.08 Million CNY	0.0%
2010 Q3	17.77 Million CNY	0.0%
2010 Q2	17.77 Million CNY	0.0%
2010 Q1	17.77 Million CNY	0.0%
2010 Q4	19.77 Million CNY	11.26%
2009 Q4	17.77 Million CNY	0.0%

Peer Operating Expenses Comparison of China Pioneer Pharma Holdings Limited

Name	Operating Expenses	Operating Expenses Difference
China Healthwise Holdings Limited	172.87 Million HKD	-182.307%
Tycoon Group Holdings Limited	-15.44 Million HKD	3259.179%
Beijing Tong Ren Tang Chinese Medicine Company Limited	423.09 Million HKD	-15.348%